The promoter group of OneSource Specialty Pharma Limited has increased its stake in the company by purchasing an additional 443,906 equity shares. These transactions occurred between January 30, 2026, and February 04, 2026, further solidifying the promoter group’s ownership. The shares were acquired through market purchases, demonstrating the promoters’ confidence in the company’s future prospects.
Promoter Group Transactions
Entities within the promoter group of OneSource Specialty Pharma Limited have collectively acquired an additional 443,906 equity shares, representing approximately 0.39% of the company’s total equity capital.
Details of Share Acquisitions
The share purchases were executed by the following entities between January 30, 2026, and February 04, 2026:
- Tenshi Pharmaceuticals Private Limited: 75,000 shares on January 30, 2026; 205,000 shares on February 02, 2026; and 85,000 shares on February 04, 2026.
- Pronomz Ventures LLP: 33,906 shares on January 30, 2026 and 45,000 shares on February 02, 2026.
Impact on Shareholding
Following these acquisitions, Tenshi Pharmaceuticals Private Limited’s shareholding increased to 3,49,40,105 shares, representing 30.48% of the total share capital. Similarly, Pronomz Ventures LLP’s shareholding increased to 3,46,50,105 shares, representing 30.23% of the total share capital. These transactions reflect a positive sentiment from key stakeholders.
Source: BSE
